GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Science Strategic Acquisition Corp Alpha (NAS:SSAAU) » Definitions » Debt-to-EBITDA

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Debt-to-EBITDA : -0.75 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Science Strategic Acquisition Alpha Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Science Strategic Acquisition Alpha's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.75 Mil. Science Strategic Acquisition Alpha's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.00 Mil. Science Strategic Acquisition Alpha's annualized EBITDA for the quarter that ended in Sep. 2022 was $-1.00 Mil. Science Strategic Acquisition Alpha's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was -0.75.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Science Strategic Acquisition Alpha's Debt-to-EBITDA or its related term are showing as below:

SSAAU' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.31   Med: 0   Max: 0
Current: -0.31

SSAAU's Debt-to-EBITDA is not ranked
in the Diversified Financial Services industry.
Industry Median: 3.96 vs SSAAU: -0.31

Science Strategic Acquisition Alpha Debt-to-EBITDA Historical Data

The historical data trend for Science Strategic Acquisition Alpha's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Science Strategic Acquisition Alpha Debt-to-EBITDA Chart

Science Strategic Acquisition Alpha Annual Data
Trend Dec20 Dec21
Debt-to-EBITDA
N/A -

Science Strategic Acquisition Alpha Quarterly Data
Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-EBITDA Get a 7-Day Free Trial - - - -0.55 -0.75

Competitive Comparison of Science Strategic Acquisition Alpha's Debt-to-EBITDA

For the Shell Companies subindustry, Science Strategic Acquisition Alpha's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Science Strategic Acquisition Alpha's Debt-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Science Strategic Acquisition Alpha's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Science Strategic Acquisition Alpha's Debt-to-EBITDA falls into.



Science Strategic Acquisition Alpha Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Science Strategic Acquisition Alpha's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -2.947
=0.00

Science Strategic Acquisition Alpha's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.75 + 0) / -0.996
=-0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2022) EBITDA data.


Science Strategic Acquisition Alpha  (NAS:SSAAU) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Science Strategic Acquisition Alpha Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Science Strategic Acquisition Alpha's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Business Description

Traded in Other Exchanges
N/A
Address
1447 2nd Street, Suite 200, Santa Monica, CA, USA, 90401
Science Strategic Acquisition Corp Alpha is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Michael Gwynne Jones director, officer: CEO 24460 MALIBU ROAD, MALIBU CA 90265
Jeff Kearl director C/O SKULLCANDY, INC., 1441 WEST UTE BLVD., SUITE 250, PARK CITY UT 84908
April Henry officer: EVP, Corporate Development C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Jennifer Rubio director C/O TISHMAN SPEYER PROPERTIES, L.P., ROCKEFELLER CENTER, 45 ROCKEFELLER PLAZA, NEW YORK NY 10111
Taylor Colette K. director C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Greg Gilman director C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Priscilla Guevara officer: Global Head of IR C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Tom Dare officer: CFO C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Peter Pham officer: President C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Headlines

No Headlines